[Login | Register]

San Diego

Biochemome Research International, Inc. (BRI) is a research and development oriented organization inspired by the concept of Biochemome (the whole biological chemotype system) in Life Sciences. Our goal is to provide new solutions for the biotechnology and pharmaceutical industries and for life sciences research. BRI develop and provide drug discovery tools and databases, and provide CRO services to pharmaceutical/bio-tech companies worldwide.

The company is headed by an entrepreneur/scientist from the United States with fifteen years experience in the drug discovery industry. This key scientist had led a modeling CADD & Cheminformatics group at the R&D Center of Boehringer Ingelheim Pharmaceuticals in Connecticut ; he has been a senior CADD & Cheminformatics software developer for Tripos and

OMG (now Accelrys) and, CADD & Cheminformatics Director for one of the largest pharmaceutical CROs in the United States . He was project leader for many CADD & Cheminformatics projects, such as, Kinases, Proteases, Nuclear Receptors, HDACs, Ion Channels, and GPCRs targeted new drug design projects. He has successfully provided CRO services to pharmaceutical or biotech companies from USA , Japan , Germany , Switzerland , Netherlands , Belgium , and Denmark .